Skip to main content
Caplight Logo









MabTics Co., Ltd.

MabTics Co., Ltd.

Private
DaejeonHealthcare & Life Scienceshttps://mabtics.co.kr/

Last Round

Strategic

Jun 1, 2024

Total Funding Raised

$2.57M

Company Overview

MabTics Co., Ltd. operates in Healthcare & Life Sciences and is based in Daejeon. Its latest recorded funding round was a Strategic round in June 2024.

MabTics Co., Ltd. is a biotechnology company that develops novel antibody therapeutics based on vessel normalization for treating vascular diseases and cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MabTics Co., Ltd. Comparables

Compare MabTics Co., Ltd. with similar companies based on industry and business-model similarity.

MabTics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
INGENIA Therapeutics
84%
Memento Medicines
83%
NEORTESBIO Inc.
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MabTics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJun 1, 2024
StrategicJul 1, 2023
SeedDec 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2024

    $940K raised with participation from Curacle Co., Ltd.

  • Jul 1, 2023

    $780K raised from Curacle Co., Ltd.

Book a demo to see all signals

For institutional investors. Book with your work email.

MabTics Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

MabTics Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MabTics Co., Ltd.'s valuation, stock price, and market status.

Is MabTics Co., Ltd. a public or private company?

MabTics Co., Ltd. is a private company.

What is the current stock price of MabTics Co., Ltd.?

MabTics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks MabTics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MabTics Co., Ltd. worth (valuation)?

Valuation information for MabTics Co., Ltd. is not publicly available.

Can I buy MabTics Co., Ltd. stock?

MabTics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MabTics Co., Ltd.'s last funding round?

MabTics Co., Ltd.'s most recent funding round was Strategic on June 1, 2024.

Who are the main investors in MabTics Co., Ltd.?

Investor information for MabTics Co., Ltd. is not publicly disclosed.

Will MabTics Co., Ltd. IPO soon?

No public IPO plans have been announced for MabTics Co., Ltd..

How can I track MabTics Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in MabTics Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersDaejeon
Year Founded2022
Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?